Stimulant Medication Guidelines for ADHD Treatment

Introduction to Stimulant Medications

The American Academy of Child and Adolescent Psychiatry recommends stimulant medications, such as methylphenidate or amphetamine, to treat attention deficit hyperactivity disorder (ADHD), which can significantly improve the ability to focus, control impulses, and function in daily life 1

The American Academy of Child and Adolescent Psychiatry notes that stimulant medications have a high potential for abuse, misuse, and addiction, and can lead to overdose and death, especially in patients with current or past substance use 1
Patients should be assessed for specific risk factors, including current substance use patterns, history of substance use disorder, impulsivity levels, and psychiatric conditions, before starting stimulant medication 1, 2

The American Heart Association recommends evaluating patients for structural heart abnormalities, cardiomyopathy, serious arrhythmias, coronary artery disease, and other serious cardiac conditions before prescribing stimulant medications 2
Stimulants can increase blood pressure by 2-4 mmHg and heart rate by 3-6 bpm on average, and patients should be monitored for signs of cardiovascular problems, such as chest pain, shortness of breath, and fainting 2

The American Psychiatric Association notes that stimulants can worsen psychosis, trigger manic episodes in bipolar disorder, or cause new psychiatric symptoms, and patients should be screened for history of psychotic symptoms, bipolar disorder, depression, and suicidal thoughts 2

The American Academy of Child and Adolescent Psychiatry recommends frequent monitoring for signs of misuse, side effects, and cardiovascular problems, including blood pressure and heart rate checks, ADHD symptom assessment, and screening for substance use and psychiatric symptoms 1, 2, 3

The American Academy of Child and Adolescent Psychiatry recommends starting with a low dose of stimulant medication and gradually increasing it based on response and tolerability, with a maximum dose of 60 mg daily for methylphenidate 1, 2

The American Academy of Child and Adolescent Psychiatry recommends considering alternative treatments, such as non-stimulant medications, psychosocial interventions, and combination approaches, if stimulants are not appropriate or effective 1, 3